share_log

Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $320

Benzinga ·  Feb 23, 2023 08:41

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and lowers the price target from $330 to $320.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment